MicroRNA Expression in Myocardial Tissue and Plasma of Patients with End-Stage Heart Failure during LVAD Support: Comparison of Continuous and Pulsatile Devices
Sjoukje I. Lok(University Medical Center Utrecht), Paula A. da Costa Martins(Universidade do Porto)
Cited by 21
Related Papers
Intercellular transfer of miR-200c-3p impairs the angiogenic capacity of cardiac endothelial cells
|Molecular Therapy|2022|22
MicroRNA-216a is essential for cardiac angiogenesis
|Molecular Therapy|2023|12
The adult heart requires baseline expression of the transcription factor Hand2 to withstand right ventricular pressure overload
|Cardiovascular Research|2021|10